kallidin, des-arg(10)- has been researched along with (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide in 1 studies
| Studies (kallidin, des-arg(10)-) | Trials (kallidin, des-arg(10)-) | Recent Studies (post-2010) (kallidin, des-arg(10)-) | Studies ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Trials ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Recent Studies (post-2010) ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) |
|---|---|---|---|---|---|
| 80 | 4 | 17 | 85 | 0 | 65 |
| Protein | Taxonomy | kallidin, des-arg(10)- (IC50) | (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide (IC50) |
|---|---|---|---|
| Transient receptor potential cation channel subfamily V member 1 | Rattus norvegicus (Norway rat) | 0.2063 | |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 0.6393 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allcock, BK; Gerovac, TA; McChesney, SL; Miranpuri, GS; Park, SW; Rajpal, S; Resnick, DK; Tilghman, JI; Turner, NA | 1 |
1 other study(ies) available for kallidin, des-arg(10)- and (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide
| Article | Year |
|---|---|
Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats.
Topics: Acrylamides; Animals; Bradykinin Receptor Antagonists; Bridged Bicyclo Compounds, Heterocyclic; Hyperalgesia; Kallidin; Male; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; TRPV Cation Channels | 2007 |